Iliac Stent Market Development Strengthened by Strategic Partnerships and Innovative Product Launches

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Iliac Stent Market- (Type (Self-expandable Stents, Balloon-expandable Stents and Others), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesion and Complete Obstructive Lesions), By End-use (Hospitals, Outpatient Facilities and Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Iliac Stent Market is valued at US$ 1.02 Bn in 2023, and it is expected to reach US$ 1.61 Bn by 2031, with a CAGR of 6.07% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2416

An iliac stent is a medical device composed of a stainless steel mesh, specifically engineered for deployment within the iliac artery-a major vessel in the pelvic region responsible for supplying blood to the lower extremities. In patients with cardiovascular conditions such as atherosclerosis, iliac stenting serves to alleviate arterial narrowing or obstruction, thereby restoring optimal blood flow.

The demand for iliac stents is being driven by several factors, including a growing preference for minimally invasive interventions, the increasing prevalence of peripheral artery disease (PAD), and ongoing advancements in stent design and biomaterials, which have improved clinical outcomes and boosted adoption rates. Additionally, heightened awareness among healthcare professionals and patients regarding the advantages of iliac stenting compared with alternative therapies is further supporting market growth.

However, market expansion is tempered by regulatory compliance requirements and the presence of alternative treatment options, which may constrain adoption. Despite these challenges, the market outlook remains favorable, underpinned by an aging global population with higher susceptibility to peripheral vascular conditions, rising investments in healthcare infrastructure, the growing availability of skilled interventional specialists, strategic initiatives by medical device companies, and increased awareness of advanced therapeutic solutions.

List of Prominent Players in the Iliac Stent Market:
• BD
• Abbott
• Boston Scientific Corporation
• W. L. Gore & Associates, Inc.
• Medtronic
• Cook
• Terumo Corporation
• iVascular
• Getinge AB
• Biotronik SE & Co KG

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics
Drivers:
The growth of the global iliac stent market is primarily driven by the expanding stent industry, which benefits from a combination of factors including the rising adoption of minimally invasive surgical procedures, continuous advancements in medical device technologies, and the increasing prevalence of cardiovascular diseases worldwide. Collectively, these elements are pivotal in propelling market expansion.

Self-expanding stents constitute a prominent segment within the market due to their demonstrated efficacy in treating conditions of the external iliac artery. Market growth is further supported by strategic initiatives from leading industry players, including the introduction of innovative product lines, successful regulatory clearances, and targeted efforts to raise awareness regarding peripheral artery disease. These actions are facilitating the rapid adoption of iliac stent solutions across global healthcare systems.

Challenges:
The iliac stent market faces several constraints that may limit its growth. Key challenges include the availability of alternative cardiovascular therapies, complex regulatory frameworks, and procedural complexities associated with angioplasty. The presence of other treatment options may influence clinicians and patients to consider alternatives over stent implantation. Additionally, risks such as product recalls and procedural complications can undermine market confidence and slow adoption rates. Regulatory approval processes also present significant barriers, as stringent compliance requirements can delay the market introduction of advanced stent technologies, thereby affecting innovation and overall market development.

Regional Trends:
North America is anticipated to maintain a dominant position in the global iliac stent market, driven by a high prevalence of peripheral artery disease, increasing public health awareness, robust governmental healthcare initiatives, and continuous technological advancements in medical devices. The region benefits from a well-established healthcare infrastructure and the presence of major market players, particularly in the United States, where an aging population and rising incidence of vascular disorders are further stimulating market demand.

Europe also represents a significant portion of the global market, supported by the growing number of vascular procedures, sustained investment in medical device innovation, and supportive government healthcare programs. The increasing adoption of minimally invasive endovascular procedures continues to drive the expansion of the iliac stent market across various European countries.

Recent Developments:
• In January 2024, Abbott announced the launch of NavitorTM, their next-generation transcatheter aortic valve implantation (TAVI) system. This minimally invasive technology will now be accessible to patients in India who suffer from severe aortic stenosis and are deemed to be at high or extreme risk for surgery. The Navitor TAVI system is the newest offering from the company's extensive structural heart transcatheter portfolio, providing patients and doctors with less invasive alternatives for treating heart disorders.
• In February 2024, BD and the world's foremost manufacturer of laboratory automation technology, Hamilton, announced a partnership to create robotics-compatible reagent kits and automated applications that allow larger-scale single-cell multi-omics experiments to be conducted with more precision and less room for human error.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2416

Segmentation of Iliac Stent Market-
Iliac Stent Market-By Type
• Self-expandable Stents
• Balloon-expandable Stents
• Others
Iliac Stent Market-By Artery Lesions
• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions
Iliac Stent Market-By End-Use
• Hospitals
• Outpatient Facilities
• Others
Iliac Stent Market-By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/iliac-stents-market/2416

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.